<DOC>
	<DOCNO>NCT02883400</DOCNO>
	<brief_summary>To study spironolactone prevent CNI kidney injury .</brief_summary>
	<brief_title>Spironolactone After Liver Transplant</brief_title>
	<detailed_description />
	<mesh_term>Spironolactone</mesh_term>
	<criteria>liver transplant dual organ transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>